1. Home
  2. BMA vs KRYS Comparison

BMA vs KRYS Comparison

Compare BMA & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco Macro S.A.  ADR (representing Ten Class B)

BMA

Banco Macro S.A. ADR (representing Ten Class B)

HOLD

Current Price

$90.82

Market Cap

5.1B

Sector

Finance

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$246.66

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMA
KRYS
Founded
1966
2015
Country
Argentina
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
6.3B
IPO Year
2006
2017

Fundamental Metrics

Financial Performance
Metric
BMA
KRYS
Price
$90.82
$246.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$96.33
$226.56
AVG Volume (30 Days)
238.5K
289.5K
Earning Date
02-25-2026
02-18-2026
Dividend Yield
2.37%
N/A
EPS Growth
N/A
275.72
EPS
0.26
6.66
Revenue
$1,943,401,172.00
$373,164,000.00
Revenue This Year
N/A
$36.14
Revenue Next Year
$8.56
$41.80
P/E Ratio
$36.64
$37.43
Revenue Growth
N/A
54.51
52 Week Low
$38.30
$122.80
52 Week High
$118.42
$265.92

Technical Indicators

Market Signals
Indicator
BMA
KRYS
Relative Strength Index (RSI) 56.75 60.83
Support Level $86.44 $235.61
Resistance Level $95.73 $257.95
Average True Range (ATR) 3.88 7.62
MACD -0.45 -1.55
Stochastic Oscillator 57.94 57.06

Price Performance

Historical Comparison
BMA
KRYS

About BMA Banco Macro S.A. ADR (representing Ten Class B)

Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: